Northpond Ventures, LLC - Q4 2022 holdings

$184 Million is the total value of Northpond Ventures, LLC's 5 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .

 Value Shares↓ Weighting
 DICE THERAPEUTICS INC$102,737,575
+53.8%
3,292,8710.0%55.73%
+19.1%
 VIGIL NEUROSCIENCE INC$52,681,225
+37.4%
4,214,4980.0%28.58%
+6.3%
 ISOPLEXIS CORP$13,653,223
-9.9%
8,808,5310.0%7.41%
-30.2%
DNAY  TELESIS BIO INC$11,812,956
-27.7%
9,844,1300.0%6.41%
-44.0%
 CANDEL THERAPEUTICS INC$3,464,035
-43.0%
1,935,2150.0%1.88%
-55.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TELESIS BIO INC8Q3 202337.2%
CANDEL THERAPEUTICS INC8Q3 20236.0%
VIGIL NEUROSCIENCE INC7Q3 202365.8%
DICE THERAPEUTICS INC6Q1 202355.7%
ISOPLEXIS CORP5Q4 202228.3%
PHENOMEX INC2Q2 20234.4%

View Northpond Ventures, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-06-02
13F-HR2023-05-15
13F-HR2023-02-01
13F-HR2022-11-14
13F-HR2022-08-01
13F-HR2022-05-16
13F-HR2022-02-15

View Northpond Ventures, LLC's complete filings history.

Export Northpond Ventures, LLC's holdings